Magnetic resonance-guided laser interstitial thermal therapy for drug-resistant epilepsy: A systematic review and individual participant data meta-analysis.


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
08 2023
Historique:
revised: 30 01 2023
received: 28 10 2022
accepted: 22 02 2023
medline: 9 8 2023
pubmed: 25 2 2023
entrez: 24 2 2023
Statut: ppublish

Résumé

Magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) has emerged as a popular minimally invasive alternative to open resective surgery for drug-resistant epilepsy (DRE). We sought to perform a systematic review and individual participant data meta-analysis to identify independent predictors of seizure outcome and complications following MRgLITT for DRE. Eleven databases were searched from January 1, 2010 to February 6, 2021 using the terms "MR-guided ablation therapy" and "epilepsy". Multivariable mixed-effects Cox and logistic regression identified predictors of time to seizure recurrence, seizure freedom, operative complications, and postoperative neurological deficits. From 8705 citations, 46 studies reporting on 450 MRgLITT DRE patients (mean age = 29.5 ± 18.1 years, 49.6% female) were included. Median postoperative seizure freedom and follow-up duration were 15.5 and 19.0 months, respectively. Overall, 240 (57.8%) of 415 patients (excluding palliative corpus callosotomy) were seizure-free at last follow-up. Generalized seizure semiology (hazard ratio [HR] = 1.78, p = .020) and nonlesional magnetic resonance imaging (MRI) findings (HR = 1.50, p = .032) independently predicted shorter time to seizure recurrence. Cerebral cavernous malformation (CCM; odds ratio [OR] = 7.97, p < .001) and mesial temporal sclerosis/atrophy (MTS/A; OR = 2.21, p = .011) were independently associated with greater odds of seizure freedom at last follow-up. Operative complications occurred in 28 (8.5%) of 330 patients and were independently associated with extratemporal ablations (OR = 5.40, p = .012) and nonlesional MRI studies (OR = 3.25, p = .017). Postoperative neurological deficits were observed in 53 (15.1%) of 352 patients and were independently predicted by hypothalamic hamartoma etiology (OR = 5.93, p = .006) and invasive electroencephalographic monitoring (OR = 4.83, p = .003). Overall, MRgLITT is particularly effective in treating patients with well-circumscribed lesional DRE, such as CCM and MTS/A, but less effective in nonlesional cases or lesional cases with a more diffuse epileptogenic network associated with generalized seizures. This study identifies independent predictors of seizure freedom and complications following MRgLITT that may help further guide patient selection.

Identifiants

pubmed: 36824029
doi: 10.1111/epi.17560
doi:

Types de publication

Systematic Review Meta-Analysis Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1957-1974

Informations de copyright

© 2023 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Références

Zack MM, Kobau R. National and state estimates of the numbers of adults and children with active epilepsy - United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;11(66):821-5.
Engel J Jr. The current place of epilepsy surgery. Curr Opin Neurol. 2018;31:192-7.
Kalilani L, Sun X, Pelgrims B, Noack-Rink M, Villanueva V. The epidemiology of drug-resistant epilepsy: a systematic review and meta-analysis. Epilepsia. 2018;59:2179-93.
Engel J Jr, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307:922-30.
Englot DJ, Breshears JD, Sun PP, Chang EF, Auguste KI. Seizure outcomes after resective surgery for extra-temporal lobe epilepsy in pediatric patients. J Neurosurg Pediatr. 2013;12:126-33.
Dwivedi R, Ramanujam B, Chandra PS, Sapra S, Gulati S, Kalaivani M, et al. Surgery for drug-resistant epilepsy in children. N Engl J Med. 2017;377:1639-47.
Behrens E, Schramm J, Zentner J, Konig R. Surgical and neurological complications in a series of 708 epilepsy surgery procedures. Neurosurgery. 1997;41:1-9. discussion 9-10, 1.
Sperling MR, Feldman H, Kinman J, Liporace JD, O'Connor MJ. Seizure control and mortality in epilepsy. Ann Neurol. 1999;46:45-50.
Rydenhag B, Silander HC. Complications of epilepsy surgery after 654 procedures in Sweden, September 1990-1995: a multicenter study based on the Swedish National Epilepsy Surgery Register. Neurosurgery. 2001;49:51-6. discussion 56-57.
Roberti F, Potolicchio SJ, Caputy AJ. Tailored anteromedial lobectomy in the treatment of refractory epilepsy of the temporal lobe: long term surgical outcome and predictive factors. Clin Neurol Neurosurg. 2007;109:158-65.
Harroud A, Bouthillier A, Weil AG, Nguyen DK. Temporal lobe epilepsy surgery failures: a review. Epilepsy Res Treat. 2012;2012:201651.
Georgiadis I, Kapsalaki EZ, Fountas KN. Temporal lobe resective surgery for medically intractable epilepsy: a review of complications and side effects. Epilepsy Res Treat. 2013;2013:752195.
Hader WJ, Tellez-Zenteno J, Metcalfe A, Hernandez-Ronquillo L, Wiebe S, Kwon CS, et al. Complications of epilepsy surgery: a systematic review of focal surgical resections and invasive EEG monitoring. Epilepsia. 2013;54:840-7.
Englot DJ, Han SJ, Rolston JD, Ivan ME, Kuperman RA, Chang EF, et al. Epilepsy surgery failure in children: a quantitative and qualitative analysis. J Neurosurg Pediatr. 2014;14:386-95.
Tebo CC, Evins AI, Christos PJ, Kwon J, Schwartz TH. Evolution of cranial epilepsy surgery complication rates: a 32-year systematic review and meta-analysis. J Neurosurg. 2014;120:1415-27.
Bjellvi J, Flink R, Rydenhag B, Malmgren K. Complications of epilepsy surgery in Sweden 1996-2010: a prospective, population-based study. J Neurosurg. 2015;122:519-25.
Gooneratne IK, Mannan S, de Tisi J, Gonzalez JC, McEvoy AW, Miserocchi A, et al. Somatic complications of epilepsy surgery over 25 years at a single center. Epilepsy Res. 2017;132:70-7.
Dorfer C, Rydenhag B, Baltuch G, Buch V, Blount J, Bollo R, et al. How technology is driving the landscape of epilepsy surgery. Epilepsia. 2020;61:841-55.
Regis J, Scavarda D, Tamura M, Villeneuve N, Bartolomei F, Brue T, et al. Gamma knife surgery for epilepsy related to hypothalamic hamartomas. Semin Pediatr Neurol. 2007;14:73-9.
Schulze-Bonhage A, Trippel M, Wagner K, Bast T, Deimling FV, Ebner A, et al. Outcome and predictors of interstitial radiosurgery in the treatment of gelastic epilepsy. Neurology. 2008;71:277-82.
Barbaro NM, Quigg M, Ward MM, Chang EF, Broshek DK, Langfitt JT, et al. Radiosurgery versus open surgery for mesial temporal lobe epilepsy: the randomized, controlled ROSE trial. Epilepsia. 2018;59:1198-207.
Catenoix H, Bourdillon P, Guenot M, Isnard J. The combination of stereo-EEG and radiofrequency ablation. Epilepsy Res. 2018;142:117-20.
Patil AA, Andrews R, Torkelson R. Stereotactic volumetric radiofrequency lesioning of intracranial structures for control of intractable seizures. Stereotact Funct Neurosurg. 1995;64:123-33.
Guenot M, Isnard J, Ryvlin P, Fischer C, Mauguiere F, Sindou M. SEEG-guided RF thermocoagulation of epileptic foci: feasibility, safety, and preliminary results. Epilepsia. 2004;45:1368-74.
Fujimoto Y, Kato A, Saitoh Y, Ninomiya H, Imai K, Hashimoto N, et al. Open radiofrequency ablation for the management of intractable epilepsy associated with sessile hypothalamic hamartoma. Minim Invasive Neurosurg. 2005;48:132-5.
Wang W, Wang W, Guo X, Zeng Y, Jiang X. Hypothalamic hamartoma causing gelastic seizures treated with stereotactic radiofrequency thermocoagulation. Epileptic Disord. 2009;11:333-8.
Quigg M, Harden C. Minimally invasive techniques for epilepsy surgery: stereotactic radiosurgery and other technologies. J Neurosurg. 2014;121 Suppl:232-40.
Cossu M, Fuschillo D, Casaceli G, Pelliccia V, Castana L, Mai R, et al. Stereoelectroencephalography-guided radiofrequency thermocoagulation in the epileptogenic zone: a retrospective study on 89 cases. J Neurosurg. 2015;123:1358-67.
Fan X, Shan Y, Lu C, An Y, Wang Y, Du J, et al. Optimized SEEG-guided radiofrequency thermocoagulation for mesial temporal lobe epilepsy with hippocampal sclerosis. Seizure. 2019;71:304-11.
Sharma M, Ball T, Alhourani A, Ugiliweneza B, Wang D, Boakye M, et al. Inverse national trends of laser interstitial thermal therapy and open surgical procedures for refractory epilepsy: a Nationwide inpatient sample-based propensity score matching analysis. Neurosurg Focus. 2020;48:E11.
Wang Y, Xu J, Liu T, Chen F, Chen S, Xie Z, et al. Magnetic resonance-guided laser interstitial thermal therapy versus stereoelectroencephalography-guided radiofrequency thermocoagulation for drug-resistant epilepsy: a systematic review and meta-analysis. Epilepsy Res. 2020;166:106397.
Curry DJ, Gowda A, McNichols RJ, Wilfong AA. MR-guided stereotactic laser ablation of epileptogenic foci in children. Epilepsy Behav. 2012;24:408-14.
Lewis EC, Weil AG, Duchowny M, Bhatia S, Ragheb J, Miller I. MR-guided laser interstitial thermal therapy for pediatric drug-resistant lesional epilepsy. Epilepsia. 2015;56:1590-8.
Wilfong AA, Curry DJ. Hypothalamic hamartomas: optimal approach to clinical evaluation and diagnosis. Epilepsia. 2013;54(Suppl 9):109-14.
Willie JT, Laxpati NG, Drane DL, Gowda A, Appin C, Hao CH, et al. Real-time magnetic resonance-guided stereotactic laser Amygdalohippocampotomy for mesial temporal lobe epilepsy. Neurosurgery. 2014;74:569-84.
Kang JY, Wu C, Tracy J, Lorenzo M, Evans J, Nei M, et al. Laser interstitial thermal therapy for medically intractable mesial temporal lobe epilepsy. Epilepsia. 2016;57:325-34.
Willie JT, Malcolm JG, Stern MA, Lowder LO, Neill SG, Cabaniss BT, et al. Safety and effectiveness of stereotactic laser ablation for epileptogenic cerebral cavernous malformations. Epilepsia. 2019;60:220-32.
Gupta K, Cabaniss B, Kheder A, Gedela S, Koch P, Hewitt KC, et al. Stereotactic MRI-guided laser interstitial thermal therapy for extratemporal lobe epilepsy. Epilepsia. 2020;61:1723-34.
Tao JX, Satzer D, Issa NP, Collins J, Wu S, Rose S, et al. Stereotactic laser anterior corpus callosotomy for Lennox-Gastaut syndrome. Epilepsia. 2020;61:1190-200.
Kohlhase K, Zollner JP, Tandon N, Strzelczyk A, Rosenow F. Comparison of minimally invasive and traditional surgical approaches for refractory mesial temporal lobe epilepsy: a systematic review and meta-analysis of outcomes. Epilepsia. 2021;62:831-45.
Wang R, Beg U, Padmanaban V, Abel TJ, Lipsman N, Ibrahim GM, et al. A systematic review of minimally invasive procedures for mesial temporal lobe epilepsy: too minimal, too fast? Neurosurgery. 2021;89:164-76.
Marathe K, Alim-Marvasti A, Dahele K, Xiao F, Buck S, O'Keeffe AG, et al. Resective, ablative and radiosurgical interventions for drug resistant mesial temporal lobe epilepsy: a systematic review and meta-analysis of outcomes. Front Neurol. 2021;12:777845.
Remick M, McDowell MM, Gupta K, Felker J, Abel TJ. Emerging indications for stereotactic laser interstitial thermal therapy in pediatric neurosurgery. Int J Hyperthermia. 2020;37:84-93.
Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221.
Schuit E, Li AH, Ioannidis JPA. How often can meta-analyses of individual-level data individualize treatment? A meta-epidemiologic study. Int J Epidemiol. 2019;48:596-608.
Hannink G, Gooszen HG, van Laarhoven CJ, Rovers MM. A systematic review of individual patient data meta-analyses on surgical interventions. Syst Rev. 2013;2:52.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med. 2009;3:e123-30.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1-e34.
Team TE. EndNote. EndNote X7 ed. Philadelphia, PA: Clarivate; 2013.
McIntosh AM, Kalnins RM, Mitchell LA, Fabinyi GC, Briellmann RS, Berkovic SF. Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence. Brain. 2004;127:2018-30.
Tao JX, Issa NP, Wu S, Rose S, Collins J, Warnke PC. Interstitial stereotactic laser anterior corpus Callosotomy: a report of 2 cases with operative technique and effectiveness. Neurosurgery. 2019;85:E569-74.
Wu C, Boorman DW, Gorniak RJ, Farrell CJ, Evans JJ, Sharan AD. The effects of anatomic variations on stereotactic laser amygdalohippocampectomy and a proposed protocol for trajectory planning. Neurosurgery. 2015;11 Suppl 2:345-56. discussion 356-347.
Vakharia VN, Sparks R, Li K, O'Keeffe AG, Miserocchi A, McEvoy AW, et al. Automated trajectory planning for laser interstitial thermal therapy in mesial temporal lobe epilepsy. Epilepsia. 2018;59:814-24.
Jermakowicz WJ, Kanner AM, Sur S, Bermudez C, D'Haese PF, Kolcun JPG, et al. Laser thermal ablation for mesiotemporal epilepsy: analysis of ablation volumes and trajectories. Epilepsia. 2017;58:801-10.
Jermakowicz WJ, Wu C, Neal E, Cajigas I, D'Haese PF, Donahue DJ, et al. Clinically significant visual deficits after laser interstitial thermal therapy for Mesiotemporal epilepsy. Stereotact Funct Neurosurg. 2019;97:347-55.
Cobourn K, Fayed I, Keating RF, Oluigbo CO. Early outcomes of stereoelectroencephalography followed by MR-guided laser interstitial thermal therapy: a paradigm for minimally invasive epilepsy surgery. Neurosurg Focus. 2018;45:E8.
Sacino M, Huang SS, Alexander H, Fayed I, Keating RF, Oluigbo CO. An initial cost-effectiveness analysis of magnetic resonance-guided laser interstitial thermal therapy in pediatric epilepsy surgery. Pediatr Neurosurg. 2020;55:141-8.
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde BW, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005-2009 Epilepsia. 2010;51:676-85.
Chang EF, Wang DD, Barkovich AJ, Tihan T, Auguste KI, Sullivan JE, et al. Predictors of seizure freedom after surgery for malformations of cortical development. Ann Neurol. 2011;70:151-62.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Bmj. 2008;336:924-6.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Bmj. 2016;355:i4919.
van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1-67.
Rubin DB. Multiple imputation for nonresponse in surveys. Hoboken: John Wiley & Sons, Inc.; 1987.
Fallah A. Time to rethink how to measure postoperative seizure outcomes for potentially curative resective. Epilepsy Behav. 2014;41:53-4.
Youngerman BE, Save AV, McKhann GM. Magnetic resonance imaging-guided laser interstitial thermal therapy for epilepsy: systematic review of technique, indications, and outcomes. Neurosurgery. 2020;86:E366-82.
Akers A, Al-Shahi Salman RIAA, Dahlem K, Flemming K, Hart B, et al. Synopsis of Guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the angioma alliance scientific advisory board clinical experts panel. Neurosurgery. 2017;80:665-80.
Ferroli P, Casazza M, Marras C, Mendola C, Franzini A, Broggi G. Cerebral cavernomas and seizures: a retrospective study on 163 patients who underwent pure lesionectomy. Neurol Sci. 2006;26:390-4.
Gao X, Yue K, Sun J, Cao Y, Zhao B, Zhang H, et al. Treatment of cerebral cavernous malformations presenting with seizures: a systematic review and meta-analysis. Front Neurol. 2020;11:590589.
Satzer D, Tao JX, Issa NP, Chen Z, Wu S, Rose S, et al. Stereotactic laser interstitial thermal therapy for epilepsy associated with solitary and multiple cerebral cavernous malformations. Neurosurg Focus. 2020;48:E12.
Van Gompim JJ, Rubio J, Cascino GD, Worrell GA, Meyer FB. Electrocorticography-guided resection of temporal cavernoma: is electrocorticography warranted and does it alter the surgical approach? J Neurosurg. 2009;110:1179-85.
San-Juan D, Diaz-Nunez IC, Ojeda-Baldez M, Barajas-Juarez VA, Gonzalez-Hernandez I, Alonso-Vanegas M, et al. Utility of electrocorticography in the surgical treatment of cavernomas presenting with pharmacoresistant epilepsy. Epileptic Disord. 2014;16:245-60.
Goel K, Pek V, Shlobin NA, Chen JS, Wang A, Ibrahim GM, et al. Clinical utility of intraoperative electrocorticography for epilepsy surgery: a systematic review and meta-analysis. Epilepsia. 2023;64:253-265.
Barot N, Batra K, Zhang J, Klem ML, Castellano J, Gonzalez-Martinez J, et al. Surgical outcomes between temporal, extratemporal epilepsies and hypothalamic hamartoma: systematic review and meta-analysis of MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy. J Neurol Neurosurg Psychiatry. 2022;93:133-143.
Elsharkawy AE, Alabbasi AH, Pannek H, Oppel F, Schulz R, Hoppe M, et al. Long-term outcome after temporal lobe epilepsy surgery in 434 consecutive adult patients. J Neurosurg. 2009;110:1135-46.
Cohen-Gadol AA, Wilhelmi BG, Collignon F, White JB, Britton JW, Cambier DM, et al. Long-term outcome of epilepsy surgery among 399 patients with nonlesional seizure foci including mesial temporal lobe sclerosis. J Neurosurg. 2006;104:513-24.
Josephson CB, Dykeman J, Fiest KM, Liu XR, Sadler RM, Jette N, et al. Systematic review and meta-analysis of standard vs selective temporal lobe epilepsy surgery. Neurology. 2013;80:1669-76.
Wiebe S, Blume WT, Girvin JP, Eliasziw M, Effectiveness, Efficiency of Surgery for Temporal Lobe Epilepsy Study G. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311-8.
Martens T, Merkel M, Holst B, Bruckner K, Lindenau M, Stodieck S, et al. Vascular events after transsylvian selective amygdalohippocampectomy and impact on epilepsy outcome. Epilepsia. 2014;55:763-9.
Duchowny M, Bhatia S. Epilepsy: preserving memory in temporal lobectomy-are networks the key? Nat Rev Neurol. 2014;10:245-6.
Andersson-Roswall L, Engman E, Samuelsson H, Malmgren K. Cognitive outcome 10 years after temporal lobe epilepsy surgery: a prospective controlled study. Neurology. 2010;74:1977-85.
Ikeda A, Miyamoyo S, Tomimoto H, Mikuni N, Fukuyama H, Hashimoto N. Effects of trans-sylvian approach to basal forebrain projection fibers: verbal memory decline after selective amygdalohippocampectomy. Epilepsia. 2005;46:334 author reply 334-335, 334; author reply 335.
Helmstaedter C, Van Roost D, Clusmann H, Urbach H, Elger CE, Schramm J. Collateral brain damage, a potential source of cognitive impairment after selective surgery for control of mesial temporal lobe epilepsy. J Neurol Neurosurg Psychiatry. 2004;75:323-6.
Lutz MT, Clusmann H, Elger CE, Schramm J, Helmstaedter C. Neuropsychological outcome after selective amygdalohippocampectomy with transsylvian versus transcortical approach: a randomized prospective clinical trial of surgery for temporal lobe epilepsy. Epilepsia. 2004;45:809-16.
Helmstaedter C. Cognitive outcomes of different surgical approaches in temporal lobe epilepsy. Epileptic Disord. 2013;15:221-39.
Dredla BK, Lucas JA, Wharen RE, Tatum WO. Neurocognitive outcome following stereotactic laser ablation in two patients with MRI-/PET+ mTLE. Epilepsy Behav. 2016;56:44-7.
Jeelani NUO, Jindahra P, Tamber MS, Poon TL, Kabasele P, James-Galton M, et al. 'Hemispherical asymmetry in the Meyer's Loop': a prospective study of visual-field deficits in 105 cases undergoing anterior temporal lobe resection for epilepsy. J Neurol Neurosur Ps. 2010;81:985-91.
Yeni SN, Tanriover N, Uyanik O, Ulu MO, Ozkara C, Karaagac N, et al. Visual field defects in selective amygdalohippocampectomy for hippocampal sclerosis: the fate of Meyer's loop during the transsylvian approach to the temporal horn. Neurosurgery. 2008;63:507-13.
Jermakowicz WJ, Ivan ME, Cajigas I, Ribot R, Jusue-Torres I, Desai MB, et al. Visual deficit from laser interstitial thermal therapy for temporal lobe epilepsy: anatomical considerations. Oper Neurosurg. 2017;13:627-33.
Egan RA, Shults WT, So N, Burchiel K, Kellogg JX, Salinsky M. Visual field deficits in conventional anterior temporal lobectomy versus amygdalohippocampectomy. Neurology. 2000;55:1818-22.
Li K, Vakharia VN, Sparks R, Franca LGS, Granados A, McEvoy AW, et al. Optimizing trajectories for cranial laser interstitial thermal therapy using computer-assisted planning: a machine learning approach. Neurotherapeutics. 2019;16:182-91.
Drane DL, Loring DW, Voets NL, Price M, Ojemann JG, Willie JT, et al. Better object recognition and naming outcome with MRI-guided stereotactic laser amygdalohippocampotomy for temporal lobe epilepsy. Epilepsia. 2015;56:101-13.
Drane DL, Willie JT, Pedersen NP, Qiu D, Voets NL, Millis SR, et al. Superior verbal memory outcome after stereotactic laser Amygdalohippocampotomy. Front Neurol. 2021;12:779495.
Youngerman BE, Oh JY, Anbarasan D, Billakota S, Casadei CH, Corrigan EK, et al. Laser ablation is effective for temporal lobe epilepsy with and without mesial temporal sclerosis if hippocampal seizure onsets are localized by stereoelectroencephalography. Epilepsia. 2018;59:595-606.
Wu CY, Jermakowicz WJ, Chakravorti S, Cajigas I, Sharan AD, Jagid JR, et al. Effects of surgical targeting in laser interstitial thermal therapy for mesial temporal lobe epilepsy: a multicenter study of 234 patients. Epilepsia. 2019;60:1171-83.
Maixner W. Hypothalamic hamartomas-clinical, neuropathological and surgical aspects. Childs Nerv Syst. 2006;22:867-73.
Polkey CE. Resective surgery for hypothalamic hamartoma. Epileptic Disord. 2003;5:281-6.
Harvey AS, Freeman JL, Berkovic SF, Rosenfeld JV. Transcallosal resection of hypothalamic hamartomas in patients with intractable epilepsy. Epileptic Disord. 2003;5:257-65.
Wait SD, Abla AA, Killory BD, Nakaji P, Rekate HL. Surgical approaches to hypothalamic hamartomas. Neurosurgical Focus. 2011;30:E2.
Ng YT, Rekate HL, Prenger EC, Chung SS, Feiz-Erfan I, Wang NC, et al. Transcallosal resection of hypothalamic hamartoma for intractable epilepsy. Epilepsia. 2006;47:1192-202.
Regis J, Lagmari M, Carron R, Hayashi M, McGonigal A, Daquin G, et al. Safety and efficacy of Gamma Knife radiosurgery in hypothalamic hamartomas with severe epilepsies: A prospective trial in 48 patients and review of the literature. Epilepsia. 2017 Jun;58 Suppl 2:60-71. doi: 10.1111/epi.13754.
Mithani K, Neudorfer C, Boutet A, Germann J, Elias GJB, Weil AG, et al. Surgical targeting of large hypothalamic hamartomas and seizure-freedom following MR-guided laser interstitial thermal therapy. Epilepsy Behav. 2021;116:107774.
Drees C, Chapman K, Prenger E, Baxter L, Maganti R, Rekate H, et al. Seizure outcome and complications following hypothalamic hamartoma treatment in adults: endoscopic, open, and gamma knife procedures. J Neurosurg. 2012;117:255-61.
Pati S, Sollman M, Fife TD, Ng YT. Diagnosis and management of epilepsy associated with hypothalamic hamartoma: an evidence-based systematic review. J Child Neurol. 2013;28:909-16.
Gadgil N, Lam S, Pan IW, LoPresti M, Wagner K, Ali I, et al. Staged magnetic resonance-guided laser interstitial thermal therapy for hypothalamic hamartoma: analysis of ablation volumes and morphological considerations. Neurosurgery. 2020;86:808-16.
Fallah A, Guyatt GH, Snead OC 3rd, Ebrahim S, Ibrahim GM, Mansouri A, et al. Predictors of seizure outcomes in children with tuberous sclerosis complex and intractable epilepsy undergoing Resective epilepsy surgery: an individual participant data meta-analysis. PLoS One. 2013;8:e53565.
Krsek P, Maton B, Jayakar P, Dean P, Korman B, Rey G, et al. Incomplete resection of focal cortical dysplasia is the main predictor of poor postsurgical outcome. Neurology. 2009;72:217-23.
Lerner JT, Salamon N, Hauptman JS, Velasco TR, Hemb M, Wu JY, et al. Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia. 2009;50:1310-35.
Bernasconi A, Bernasconi N, Bernhardt BC, Schrader D. Advances in MRI for ‘cryptogenic’ epilepsies. Nat Rev Neurol. 2011;7:99-108.
Bernasconi A, Cendes F, Theodore WH, Gill RS, Koepp MJ, Hogan RE, et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: a consensus report from the international league against epilepsy neuroimaging task force. Epilepsia. 2019;60:1054-68.
Onal C, Otsubo H, Araki T, Chitoku S, Ochi A, Weiss S, et al. Complications of invasive subdural grid monitoring in children with epilepsy. J Neurosurg. 2003;98:1017-26.
Hu WH, Zhang C, Zhang K, Shao XQ, Zhang JG. Hemispheric surgery for refractory epilepsy: a systematic review and meta-analysis with emphasis on seizure predictors and outcomes. J Neurosurg. 2016;124:952-61.
Wu SS, Issa NP, Lacy M, Satzer D, Rose SL, Yang CW, et al. Surgical outcomes and EEG prognostic factors after stereotactic laser amygdalohippocampectomy for mesial temporal lobe epilepsy. Front Neurol. 2021;12:654668.
Salmenpera TM, Duncan JS. Imaging in epilepsy. J Neurol Neurosur Ps. 2005;76:2-10.
Bernasconi A, Bernasconi N. The role of MRI in the treatment of drug-resistant focal epilepsy. Eur Neurol. 2022;85:333-41.
Yuan J, Chen Y, Hirsch E. Intracranial electrodes in the presurgical evaluation of epilepsy. Neurol Sci. 2012;33:723-9.
Englot DJ, Nagarajan SS, Imber BS, Raygor KP, Honma SM, Mizuiri D, et al. Epileptogenic zone localization using magnetoencephalography predicts seizure freedom in epilepsy surgery. Epilepsia. 2015;56:949-58.
Albert GW, Ibrahim GM, Otsubo H, Ochi A, Go CY, Snead OC 3rd, et al. Magnetoencephalography-guided resection of epileptogenic foci in children. J Neurosurg Pediatr. 2014;14:532-7.
Edmonds BD, Welch W, Sogawa Y, Mountz J, Bagic A, Patterson C. The role of magnetoencephalography and single-photon emission computed tomography in evaluation of children with drug-resistant epilepsy. J Child Neurol. 2021;36:673-9.
Widjaja E, Papastavros T, Sander B, Snead C, Pechlivanoglou P. Early economic evaluation of MRI-guided laser interstitial thermal therapy (MRgLITT) and epilepsy surgery for mesial temporal lobe epilepsy. PLoS One. 2019;14:e0224571.
Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI, Anti-Lymphocyte Antibody Induction Therapy Study G. Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med. 2002;21:371-87.
Lambert PC, Sutton AJ, Abrams KR, Jones DR. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. Journal of Clinical Epidemiology. 2002;55:86-94.
Tugwell P, Knottnerus JA. Advantages of individual patient data analysis in systematic reviews. J Clin Epidemiol. 2010;63:233-4.
van Walraven C. Individual patient meta-analysis-rewards and challenges. J Clin Epidemiol. 2010;63:235-7.
Fisher DJ, Copas AJ, Tierney JF, Parmar MK. A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners. J Clin Epidemiol. 2011;64:949-67.

Auteurs

Jia-Shu Chen (JS)

Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.

Audrey-Anne Lamoureux (AA)

Division of Pediatric Neurosurgery, Department of Surgery, Sainte Justine Hospital, University of Montreal, Montreal, Quebec, Canada.

Nathan A Shlobin (NA)

Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Lior M Elkaim (LM)

Division of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Andrew Wang (A)

Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.

George M Ibrahim (GM)

Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Sami Obaid (S)

Division of Pediatric Neurosurgery, Department of Surgery, Sainte Justine Hospital, University of Montreal, Montreal, Quebec, Canada.
Division of Neurosurgery, University of Montreal Hospital Center, Montreal, Quebec, Canada.

Adil Harroud (A)

Division of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Elena Guadagno (E)

Harvey E. Beardmore Division of Pediatric Surgery, McGill University Health Center, Montreal, Quebec, Canada.

Evan Dimentberg (E)

Division of Pediatric Neurosurgery, Department of Surgery, Sainte Justine Hospital, University of Montreal, Montreal, Quebec, Canada.
Faculty of Medicine, Université Laval, Quebec City, Quebec, Canada.

Alain Bouthillier (A)

Division of Neurosurgery, University of Montreal Hospital Center, Montreal, Quebec, Canada.

Boris C Bernhardt (BC)

McConnell Brain Imaging Center, Montreal Neurological Institute and Hospital, McGill University, Quebec, Canada.

Dang K Nguyen (DK)

Division of Neurology, University of Montreal Medical Center, Montreal, Quebec, Canada.

Aria Fallah (A)

Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.

Alexander G Weil (AG)

Division of Pediatric Neurosurgery, Department of Surgery, Sainte Justine Hospital, University of Montreal, Montreal, Quebec, Canada.
Division of Neurosurgery, University of Montreal Hospital Center, Montreal, Quebec, Canada.
Brain and Child Development Axis, Sainte Justine Research Center, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH